| human | Q5 |
| P213 | ISNI | 0000000387027021 |
| P8189 | J9U ID | 987007386647305171 |
| P691 | NL CR AUT ID | ntk20221165287 |
| P496 | ORCID iD | 0000-0002-4475-8142 |
| P214 | VIAF cluster ID | 313521328 |
| P69 | educated at | Johns Hopkins Medicine | Q50363516 |
| Columbia College | Q4569677 | ||
| P108 | employer | Mayo Clinic Hospital – Jacksonville | Q6797499 |
| P101 | field of work | medicine | Q11190 |
| stroke | Q12202 | ||
| neurology | Q83042 | ||
| cerebrovascular disease | Q3010352 | ||
| P735 | given name | James | Q677191 |
| James | Q677191 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | scientist | Q901 |
| physician | Q39631 | ||
| neurologist | Q783906 | ||
| P21 | sex or gender | male | Q6581097 |
| Q30412878 | 17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status |
| Q38540298 | 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the Ame |
| Q91120386 | A Cross-Sectional Analysis of Migraine-Related Disability in CADASIL: A Mayo Clinic Cohort |
| Q28943330 | A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release |
| Q33981695 | A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach |
| Q30436684 | A survey of the SWISS researchers on the impact of sibling privacy protections on pedigree recruitment |
| Q30425779 | APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study |
| Q30370833 | APOE ε variants increase risk of warfarin-related intracerebral hemorrhage. |
| Q37826143 | Acute Ischemic Stroke Management: Medical Management |
| Q35018261 | Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research |
| Q37242531 | Advances in Genetics 2010 |
| Q34322732 | Advances in stroke: genetics 2012. |
| Q35853183 | Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial |
| Q42488457 | Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats |
| Q48443754 | Aging is neuroprotective during global ischemia but leads to increased caspase-3 and apoptotic activity in hippocampal neurons |
| Q30405640 | Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study. |
| Q42291847 | Alpha-1 antitrypsin dysfunction and large artery stroke |
| Q39767732 | Ambulance-based assessment of NIH Stroke Scale with telemedicine: A feasibility pilot study |
| Q48923756 | Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels |
| Q42536318 | Anticoagulant and defibrinogenating agents in acute ischemic stroke and cerebral venous thrombosis |
| Q74426808 | Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association) |
| Q34726717 | Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). |
| Q30414047 | Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals |
| Q30420031 | Are myocardial infarction--associated single-nucleotide polymorphisms associated with ischemic stroke? |
| Q28655857 | Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data |
| Q64228297 | Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis |
| Q36597633 | Association of MTHFR C677T Genotype With Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype. |
| Q30440379 | Association of integrin alpha2 gene variants with ischemic stroke |
| Q36181345 | Association of prediabetes and diabetes with stroke symptoms: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study |
| Q37442583 | Association of the APOE, MTHFR and ACE Genes Polymorphisms and Stroke in Zambian Patients |
| Q34148204 | Asymptomatic carotid stenosis: What we can learn from the next generation of randomized clinical trials |
| Q35119694 | Ataxin-2 repeat-length variation and neurodegeneration |
| Q44462161 | Behavioral symptoms in long-term survivors of ischemic stroke |
| Q92613175 | Big Data Approaches to Phenotyping Acute Ischemic Stroke Using Automated Lesion Segmentation of Multi-Center Magnetic Resonance Imaging Data |
| Q94547959 | Brain Volume: An Important Determinant of Functional Outcome After Acute Ischemic Stroke |
| Q48118986 | Brain injury after cardiopulmonary arrest and its assessment with diffusion-weighted magnetic resonance imaging |
| Q30415122 | Burden of blood pressure-related alleles is associated with larger hematoma volume and worse outcome in intracerebral hemorrhage |
| Q30416687 | Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage |
| Q92381298 | CNS small vessel disease: A clinical review |
| Q43151328 | Camera in the emergency department: the evolution of stroke telemedicine |
| Q24649888 | Candidate gene polymorphisms for ischemic stroke |
| Q30300252 | Candidate-gene analysis of white matter hyperintensities on neuroimaging. |
| Q48458920 | Cardiac papillary fibroelastoma as a cause of recurrent ischemic strokes: the diagnostic value of serial transesophageal echocardiography |
| Q104572263 | Carotid Artery Stenosis in a Young Asymptomatic Patient: The Value of Multimodal Cross-sectional Imaging |
| Q60692415 | Carotid Endarterectomy for Asymptomatic Stenosis |
| Q60692402 | Carotid Stenting Versus Carotid Endarterectomy: What Did the Carotid Revascularization Endarterectomy Versus Stenting Trial Show and Where Do We Go From Here? |
| Q91075013 | Carotid revascularization and medical management for asymptomatic carotid stenosis - Hemodynamics (CREST-H): Study design and rationale |
| Q40219352 | Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials |
| Q91068860 | Cerebral Small Vessel Disease Burden and All-Cause Mortality: Mayo Clinic Florida Familial Cerebrovascular Diseases Registry |
| Q50556922 | Cerebral infarction in older age: nature or (lack of) nurture? |
| Q44971179 | Characteristics of 100 consecutive patients presenting with orthostatic hypotension |
| Q31057160 | Choice of neuroimaging in perioperative acute stroke management |
| Q104694791 | Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis |
| Q38371994 | Clinical need, design, and goals for the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis trial |
| Q37932151 | Clinical, Anatomic, and Procedural Durability of Carotid Revascularization |
| Q35883510 | Clinically translated ischemic stroke genomics |
| Q104800694 | Cognitive Impairment in Patients with Stroke |
| Q91576091 | Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease |
| Q35639599 | Common NOTCH3 Variants and Cerebral Small-Vessel Disease |
| Q30428008 | Common mitochondrial sequence variants in ischemic stroke |
| Q30419337 | Common variants at 6p21.1 are associated with large artery atherosclerotic stroke |
| Q30414654 | Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage |
| Q30370974 | Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease |
| Q30301277 | Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. |
| Q46661356 | Computer-assisted volumetric analysis compared with ABC/2 method for assessing warfarin-related intracranial hemorrhage volumes. |
| Q97075878 | Contemporary Management of Acute Ischemic Stroke Across the Continuum: From TeleStroke to Intra-Arterial Management |
| Q34652535 | Contrasting the neurologic complications of cardiac transplantation in adults and children |
| Q48958871 | Correlation of proband and sibling stroke latency: the SWISS Study |
| Q38420587 | Creation of a bilingual Spanish-English version of the Questionnaire for Verifying Stroke-free Status |
| Q42432752 | Decoding cryptogenic cardioembolism |
| Q81596616 | Defining stroke risks in sickle cell anemia |
| Q38368492 | Design and rationale for examining neuroimaging genetics in ischemic stroke: The MRI-GENIE study |
| Q64922771 | Destigmatizing Migraine. |
| Q90923861 | Detailed phenotyping of posterior vs. anterior circulation ischemic stroke: a multi-center MRI study. |
| Q88285208 | Diagnosis and Management of Acute Ischemic Stroke |
| Q36867587 | Diagnosis and invasive management of carotid atherosclerotic stenosis |
| Q97518140 | Diffusion-Weighted Imaging, MR Angiography, and Baseline Data in a Systematic Multicenter Analysis of 3,301 MRI Scans of Ischemic Stroke Patients-Neuroradiological Review Within the MRI-GENIE Study |
| Q88215260 | Discovery of a cause of vein of Galen malformations |
| Q57306411 | Distinguishing primary angiitis of the central nervous system from cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: The importance of family history |
| Q83982318 | Does mitochondrial DNA have a protective role in stroke? |
| Q92481599 | Does the Association of Diabetes With Stroke Risk Differ by Age, Race, and Sex? Results From the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study |
| Q64880421 | Duplex velocity criteria for carotid endarterectomy. |
| Q30410263 | Early-onset stroke and vasculopathy associated with mutations in ADA2 |
| Q73906446 | Editorial comment--Vascular thickness and calcification as markers of atherosclerotic burden |
| Q30430617 | Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials |
| Q30384553 | Effect of genetic variants associated with plasma homocysteine levels on stroke risk |
| Q89801763 | Effects of Genetic Variants on Stroke Risk |
| Q96615696 | Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial |
| Q80607324 | Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment |
| Q51059009 | Enhancing Recovery After Acute Ischemic Stroke with Donepezil as an Adjuvant Therapy to Standard Medical Care: Results of a Phase IIa Clinical Trial |
| Q30299918 | Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection |
| Q30440503 | Ethical and methodological issues in pedigree stroke research |
| Q58672548 | Ethics consultations and patients with neurological diseases |
| Q39422479 | Evaluation and Management of Atherosclerotic Carotid Stenosis |
| Q81338738 | Evaluation of subclinical cerebral injury and neuropsychologic function in patients undergoing carotid endarterectomy |
| Q88657924 | Every physician should discourage cigarette smoking |
| Q38372823 | Factors Associated With Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial |
| Q92230559 | Factors influencing credentialing of interventionists in the CREST-2 trial |
| Q50762682 | Failure to wean from a ventilator caused by ANNA-1 seropositive paraneoplastic syndrome |
| Q48275213 | Familial clustering of stroke according to proband age at onset of presenting ischemic stroke |
| Q95784298 | Familial hypercholesterolemia: stroke and the broader perspective |
| Q30440498 | Family history of stroke and severity of neurologic deficit after stroke |
| Q48691811 | Feasibility of an affected sibling pair study in ischemic stroke: results of a 2-center family history registry |
| Q81444891 | Fragile vessels: handle with care |
| Q34503278 | Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population |
| Q61807445 | Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting |
| Q30408462 | Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic stroke. |
| Q30360595 | Genetic overlap between diagnostic subtypes of ischemic stroke |
| Q29417025 | Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies |
| Q34522989 | Genetic stroke syndromes |
| Q30414709 | Genetic susceptibility to ischemic stroke |
| Q37012822 | Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke |
| Q30275688 | Genetic variants in CETP increase risk of intracerebral hemorrhage |
| Q24630394 | Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk |
| Q30275184 | Genetic variation at 16q24.2 is associated with small vessel stroke |
| Q30422717 | Genetic variation at CR1 increases risk of cerebral amyloid angiopathy |
| Q91821857 | Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage |
| Q38168149 | Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association |
| Q37462565 | Genetics in clinical trials |
| Q35094704 | Genetics of Vascular Dementia |
| Q36018306 | Genetics of cerebrovascular disorders |
| Q39429524 | Genetics of ischaemic stroke |
| Q37350213 | Genetics of ischemic stroke: inheritance of a sporadic disorder |
| Q73209002 | Genetics of stroke |
| Q86856799 | Genetics of stroke: impact and limitations of evolving technology: introduction |
| Q58084895 | Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke |
| Q36336900 | Genetics of vascular cognitive impairment: the opportunity and the challenges |
| Q30354370 | Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2 |
| Q97641775 | Genome-Wide Association Study Meta-Analysis of Stroke in 22 000 Individuals of African Descent Identifies Novel Associations With Stroke |
| Q30410548 | Genome-wide analysis of blood pressure variability and ischemic stroke |
| Q24620065 | Genome-wide association analyses identify 18 new loci associated with serum urate concentrations |
| Q30428070 | Genome-wide association analysis of ischemic stroke in young adults |
| Q29417129 | Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke |
| Q92727483 | Genome-wide association study of cerebral small vessel disease reveals established and novel loci |
| Q30360969 | Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke. |
| Q30430623 | Genomic risk profiling of ischemic stroke: results of an international genome-wide association meta-analysis |
| Q89580078 | Globus Pallidus Externus Deep Brain Stimulation Treats Insomnia in a Patient With Parkinson Disease |
| Q42205611 | Grand Challenge: The Emerging Field of Neurohospitalist Medicine |
| Q34153132 | Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q92885460 | Haptoglobin genotype and aneurysmal subarachnoid hemorrhage: Individual patient data analysis |
| Q37080140 | Heart rate and ischemic stroke: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study |
| Q30412882 | Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage |
| Q36143269 | Heritability of young- and old-onset ischaemic stroke. |
| Q47565553 | Heterogeneity of Moyamoya disease: after a decade of linkage, is there new hope for a gene? |
| Q48400062 | High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study |
| Q40551608 | High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study). |
| Q89576118 | Higher Long-Term Mortality with Carotid Artery Stenting in Asymptomatic Male Compared with Female Patients in the Southeastern Vascular Study Group |
| Q46691847 | Hippocampal progenitor cells express nestin following cerebral ischemia in rats |
| Q37868578 | Hospital-based management of acute ischemic stroke following intravenous thrombolysis |
| Q30440385 | IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations |
| Q35888482 | Identifying a high stroke risk subgroup in individuals with heart failure |
| Q30445563 | Impact of restricting enrollment in stroke genetics research to adults able to provide informed consent |
| Q54191609 | Improving practice through neurovascular board |
| Q35953248 | Incidence of stroke symptoms among adults with chronic kidney disease: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study |
| Q91841582 | Incorporation of Telestroke into Neurology Residency Training: "Time Is Brain and Education" |
| Q35875818 | Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) |
| Q56354690 | Influences Hematoma Volume and Outcome in Spontaneous Intracerebral Hemorrhage |
| Q50076998 | Informing vs Changing the Practice of Carotid Revascularization |
| Q30444346 | Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review |
| Q38772425 | Interventions for Extracranial Carotid Artery Stenosis: An Update |
| Q36103614 | Interventions to increase enrollment in a large multicenter phase 3 trial of carotid stenting vs. endarterectomy |
| Q89206836 | Introduction to the Symposium on Neurosciences |
| Q48409032 | Is Hormone Replacement a Risk Factor for Ischemic Stroke in Women With Factor V Leiden Mutation? |
| Q37047071 | Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension |
| Q35183945 | Ischaemic stroke: one or several complex genetic disorders? |
| Q36396809 | Ischemic stroke as a complex genetic disorder |
| Q36637803 | Ischemic stroke is associated with the ABO locus: the EuroCLOT study |
| Q30438484 | Joint Commission primary stroke center certification does not affect proband enrollment: the siblings with ischemic stroke study |
| Q34126355 | LRRK2 variation and Parkinson's disease in African Americans |
| Q48281987 | Lack of aggregation of ischemic stroke subtypes within affected sibling pairs |
| Q36502544 | Lessons from adult stroke trials |
| Q83809387 | Letter by Freeman et al regarding article, "Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial" |
| Q36921655 | Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis |
| Q35832752 | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk |
| Q35117218 | Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study. |
| Q30356365 | Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration. |
| Q35114958 | Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). |
| Q41635572 | Manipulation of Coagulation Factors in Acute Stroke |
| Q38372095 | Mayo Acute Stroke Trial for Enhancing Recovery (MASTER) protocol |
| Q51717091 | Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation |
| Q36198690 | Mediators of the Age Effect in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). |
| Q64057250 | Mesenchymal stem cells for hemorrhagic stroke: status of preclinical and clinical research |
| Q30279161 | Meta-Analysis of Genome-Wide Association Studies Identifies Genetic Risk Factors for Stroke in African Americans |
| Q30410768 | Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. |
| Q30410308 | Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage |
| Q100725292 | Mitigating the effects of COVID-19 pandemic on controlling vascular risk factors among participants in a carotid stenosis trial |
| Q50531000 | Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes |
| Q33553928 | Multilocus genetic risk score associates with ischemic stroke in case-control and prospective cohort studies |
| Q35705431 | Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids |
| Q44772240 | NINDS Stroke Genetics Network (SiGN) Experience with the Causative Classification System |
| Q30417040 | NOTCH3 variants and risk of ischemic stroke |
| Q80482540 | New advances in identifying genetic anomalies in stroke-prone probands |
| Q35148409 | New advances in identifying genetic anomalies in stroke-prone probands |
| Q34664010 | New information on the genetics of stroke |
| Q27004125 | Nonconvulsive status with metronidazole |
| Q80482533 | Not so accidental outcomes following cerebrovascular accidents |
| Q44090198 | Novel insights into the genetics of intracerebral hemorrhage |
| Q42941421 | Pacemakers as Atrial Fibrillation Detectors: Finding Racial Differences and Opportunities for Preventing Stroke |
| Q42523560 | Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma |
| Q87976310 | Partial loss of function of colony-stimulating factor 1 receptor in a patient with white matter abnormalities |
| Q30301308 | Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics network |
| Q92971678 | Patient perception of physician empathy in stroke telemedicine |
| Q37425335 | Pharmacogenetics and stroke |
| Q92135441 | Pharmacotherapy for Patients with Atrial Fibrillation and Cerebral Microbleeds |
| Q30445412 | Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke |
| Q35095151 | Picking the good apples: statistics versus good judgment in choosing stent operators for a multicenter clinical trial |
| Q47176159 | Planning genetic studies and human stroke: sample size estimates based on family history data |
| Q101573213 | Plasma neurofilament light predicts mortality in patients with stroke |
| Q60776949 | Postprandial limb-shaking: an unusual presentation of transient cerebral ischemia |
| Q100433284 | Predicting Who Will Experience Cerebral Hemorrhage When Anticoagulated |
| Q84577062 | Predictors of poor neurologic outcome after induced mild hypothermia following cardiac arrest |
| Q30438233 | Prestroke physical activity and early functional status after stroke |
| Q103836983 | Prevalence of Intracranial Aneurysms in Patients with Infrarenal Abdominal Aortic Aneurysms: A Multicenter Experience |
| Q90296409 | Prevalence of Previously Undiagnosed Abdominal Aortic Aneurysms in Patients with Intracranial Aneurysms: From the Brain and Aortic Aneurysms Study (BAAS) |
| Q81427269 | Primary CNS vasculitis with spinal cord involvement |
| Q48805579 | Primary central nervous system vasculitis presenting with intracranial hemorrhage |
| Q31145082 | Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome |
| Q44463926 | Primary central nervous system vasculitis: analysis of 101 patients |
| Q46407220 | Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy |
| Q34544496 | Principal-component analysis for assessment of population stratification in mitochondrial medical genetics |
| Q30439096 | Proband race/ethnicity affects pedigree completion rate in a genetic study of ischemic stroke |
| Q125028006 | Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis |
| Q53489117 | Protecting the privacy of family members in research |
| Q92503540 | Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes |
| Q92129200 | Quality Assurance for Carotid Stenting in the CREST-2 Registry |
| Q33911000 | Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study |
| Q50488519 | Raising the red flag over white-matter changes |
| Q95334357 | Rapidly Resolving and Recurrent Contralateral Subdural Hematoma From Disseminated Intravascular Coagulation |
| Q85223328 | Rapidly progressive primary central nervous system vasculitis |
| Q30279111 | Rare Coding Variation and Risk of Intracerebral Hemorrhage |
| Q30299967 | Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project |
| Q30393812 | Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project |
| Q34247395 | Rare variants in ischemic stroke: an exome pilot study |
| Q99577119 | Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial |
| Q45184495 | Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. |
| Q75225027 | Reliability of the questionnaire for verifying stroke-free status |
| Q46232188 | Reperfusion Therapy for Acute Ischemic Stroke: How Should We React to the Third Interventional Management of Stroke (IMS III) Trial? |
| Q30414911 | Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial |
| Q34469861 | Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin |
| Q64074336 | Safety and Efficacy of Intraventricular Delivery of Bone Marrow-Derived Mesenchymal Stem Cells in Hemorrhagic Stroke Model |
| Q43044952 | Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system. |
| Q35076095 | Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) |
| Q98734961 | Safety, Tolerability, and Efficacy of Pain Reduction by Gabapentin for Acute Headache and Meningismus After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study |
| Q30248281 | Screening individuals with intracranial aneurysms for abdominal aortic aneurysms is cost-effective based on estimated coprevalence |
| Q35257273 | Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study |
| Q35546423 | Sensitivity and specificity of stroke symptom questions to detect stroke or transient ischemic attack |
| Q30436210 | Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke |
| Q92122854 | Severity of White Matter Hyperintensities and Effects on All-Cause Mortality in the Mayo Clinic Florida Familial Cerebrovascular Diseases Registry |
| Q30440487 | Sex differences in stroke evaluations in the Ischemic Stroke Genetics Study |
| Q30444521 | Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke |
| Q30456383 | Shared associations of nonatherosclerotic, large-vessel, cerebrovascular arteriopathies: considering intracranial aneurysms, cervical artery dissection, moyamoya disease and fibromuscular dysplasia |
| Q30366137 | Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. |
| Q27008212 | Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants |
| Q30424818 | Siblings with ischemic stroke study: results of a genome-wide scan for stroke loci |
| Q48212307 | Sirkka-Liisa Leinonen |
| Q47212331 | Spanish cross-cultural adaptation and validation of the National Institutes of Health Stroke Scale |
| Q30310914 | Spouses and unrelated friends of probands as controls for stroke genetics studies |
| Q34151647 | Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project |
| Q24619941 | Stenting versus endarterectomy for treatment of carotid-artery stenosis |
| Q28658238 | Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes |
| Q35602462 | Stroke Genetics Update: 2011 |
| Q36655779 | Stroke Symptoms as a Predictor of Future Hospitalization |
| Q46768205 | Stroke Telemedicine: State of Affairs–Reply–I. |
| Q30577734 | Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). |
| Q81351189 | Stroke and the american presidency |
| Q30440501 | Stroke genetic research and adults with impaired decision-making capacity: a survey of IRB and investigator practices |
| Q42751865 | Stroke genome-wide association studies: the large numbers imperative |
| Q51900904 | Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with a decrease in indices of mental and physical functioning |
| Q57462516 | Stroke-related epilepsy |
| Q36953709 | Stroke-related translational research. |
| Q38567462 | Stroke: advances in medical therapy and acute stroke intervention |
| Q30438901 | Structural genomic variation in ischemic stroke |
| Q81370684 | Subtyping in ischemic stroke genetic research |
| Q36952445 | TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease |
| Q36100356 | Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial |
| Q94482809 | The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic |
| Q34102771 | The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase |
| Q57157880 | The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation |
| Q34827386 | The Effect of Survival Bias on Case-Control Genetic Association Studies of Highly Lethal Diseases |
| Q86999748 | The High Risk of Low Distal Flow |
| Q24794936 | The Ischemic Stroke Genetics Study (ISGS) Protocol |
| Q86804993 | The Relationship Between Serum Neuron-Specific Enolase Levels and Severity of Bleeding and Functional Outcomes in Patients With Nontraumatic Subarachnoid Hemorrhage |
| Q24803218 | The Siblings With Ischemic Stroke Study (SWISS) protocol |
| Q30446682 | The Siblings With Ischemic Stroke Study (SWISS): a progress report |
| Q30436022 | The impact of privacy protections on recruitment in a multicenter stroke genetics study |
| Q35864053 | The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis |
| Q30245027 | The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis |
| Q40169066 | Thrombolysis for acute ischemic stroke: future directions |
| Q34680512 | Thrombolytic treatment of acute ischemic stroke |
| Q36613693 | Time From Symptoms to Carotid Endarterectomy or Stenting and Perioperative Risk |
| Q92657265 | Transcarotid Artery Revascularization Results in Low Rates of Periprocedural Neurologic Events, Myocardial Infarction, and Death |
| Q45064328 | Translational Stroke Research: Vision and Opportunities |
| Q56069174 | Traumatic Brain Injury and Stroke |
| Q92157399 | Treating chronic migraine in CADASIL with calcitonin gene-related peptide receptor antagonism |
| Q28190975 | Urinary 11-dehydro-thromboxane B2 and coagulation activation markers measured within 24 h of human acute ischemic stroke |
| Q34392784 | Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination |
| Q30429407 | Variants at APOE influence risk of deep and lobar intracerebral hemorrhage |
| Q82503779 | Vascular dementia may be easier to treat than diagnose |
| Q33910376 | Verifying the stroke-free phenotype by structured telephone interview |
| Q81351796 | Views on the use of tissue plasminogen activator in acute ischemic stroke: a state-wide survey among neurologists and emergency medicine physicians in Indiana |
| Q36059756 | What stroke symptoms tell us: association of risk factors and individual stroke symptoms in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study |
| Q96130221 | White matter hyperintensity burden in acute stroke patients differs by ischemic stroke subtype |
| Q64903239 | White matter hyperintensity quantification in large-scale clinical acute ischemic stroke cohorts - The MRI-GENIE study. |
| Q30429797 | White matter hyperintensity volume is increased in small vessel stroke subtypes |
| Q37599387 | Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. |
| Q37344135 | Whole genome approaches in ischemic stroke |
| Q36954988 | Willingness of ischemic stroke patients to donate DNA for genetic research: a systematic review |
| Q93128345 | X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia |
| Q58568725 | point mutations and familial intracranial aneurysms |
Search more.